ENHANCE EXTERNAL COUNTERPULSATING TS3 *

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2005-08-18 for ENHANCE EXTERNAL COUNTERPULSATING TS3 * manufactured by Vasomedical, Inc..

Event Text Entries

[386461] First therapy session stopped 2x due to pt c/o left leg numbness and pain. Foot appeared mottled and cool. Physician ordered doppler - absent left dp/pt pulses and foot not improving despite attempts by pt to improve circulation. Pt admitted.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2435300-2005-00004
MDR Report Key629103
Report Source07
Date Received2005-08-18
Date of Report2005-08-18
Date of Event2005-08-10
Date Mfgr Received2005-08-15
Device Manufacturer Date2001-08-01
Date Added to Maude2005-08-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactTHOMAS VARRICCHIONE
Manufacturer Street180 LINDEN AVE.
Manufacturer CityWESTBURY NY 11590
Manufacturer CountryUS
Manufacturer Postal11590
Manufacturer Phone5169974600
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameENHANCE EXTERNAL COUNTERPULSATING
Generic NameDEVICE, EXTERNAL, COUNTER-PULSATING
Product CodeDRN
Date Received2005-08-18
Model NumberTS3
Catalog Number*
Lot Number*
ID Number*
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrN
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key618715
ManufacturerVASOMEDICAL, INC.
Manufacturer Address* WESTBURY NY * US
Baseline Brand NameEECP THERAPY SYSTEM
Baseline Generic NameEECP
Baseline Model NoTS3
Baseline Catalog NoNA
Baseline IDNA
Baseline Device FamilyDEVICE, COUNTER-PULSATING, EXTERNAL
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK003469
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2005-08-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.